- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Oncothyreon Inc+ Add to Watchlist
ONTY:US1.7500 USD 0.0200 1.13%
As of 12:30:17 ET on 12/20/2013.
Company Profile for Oncothyreon Inc (ONTY)
Oncothyreon Inc. develops therapeutic approaches to cancer management. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer. Oncothyreon delivers its services to customers throughout the United States.
Key Executives for Oncothyreon Inc (ONTY)
|Robert L KirkmanPresident/CEO||Gary ChristiansonChief Operating Officer|
|Julie M EastlandVP:Corporate Dev/CFO/Secy||Scott PetersonVP:Research & Dev/Chief Scientific Ofcr|
|Diana HausmanVP:Clinical Dev/Chief Medical Ofcr||Jane TullochDirector:Investor Relations|